Abstract | Neural stem cells (NSCs) are found in two regions in the adult brain: the subgranular zone (SGZ) in the hippocampal dentate gyrus and the subventricular zone (SVZ) adjacent to the lateral ventricles. Similarly to other somatic stem cells, adult NSCs are found within specialized niches that are organized to facilitate NSC self-renewal. Alterations in stem-cell homeostasis can contribute to the consequences of neurodegenerative diseases, healthy ageing and tissue repair after damage. Insulin and the insulin-like growth factors (IGFs) function in stem-cell homeostasis across species. Studies in the mammalian central nervous system support essential roles for IGF and/or insulin signalling in NSC self-renewal, neurogenesis, cognition and sensory function through distinct ligand-receptor interactions. IGF-II is of particular interest as a result of its production by the choroid plexus and presence in cerebrospinal fluid (CSF). CSF regulates and supports the development, division and migration of cells in the adult brain and is required for NSC maintenance. In this Review, we discuss emerging data on the functions of IGF-II and IGF and/or insulin receptor signalling in the context of NSC regulation in the SVZ and SGZ. We also propose a model for IGF-II in which the choroid plexus is a major component of the NSC niche.
Introduction
Adult neural stem cells (NSCs) are found within special ized niches, which are organized to promote interactions between NSCs and the cerebrospinal fluid (CSF), cerebral microvasculature, extracellular matrix components and meninges. [1] [2] [3] Two regions function as centres of neuro genesis in the adult brain: the subgranular zone (SGZ) in the hippocampal dentate gyrus and the subventricular zone (SVZ) adjacent to the lateral ventricles. Whereas research into the origins of adult NSCs within the SGZ and SVZ, as well as the generation and migration of their progeny, has been an area of intense activity, the micro environment of the niche has only lately been studied in detail. 4 A unique feature of NSCs that reside in the SVZ is that they extend a process through the wall of the ventri cle to contact the CSF. Whereas the CSF was once thought to be a simple ultrafiltrate of plasma, it is now known that this fluid is rich in polypeptides, growth factors and hormones that promote maintenance of NSCs. Many of these factors are produced by the choroid plexus 5 and include ciliary neurotrophic factor (CNTF), leukaemia inhibitory factor (LIF), members of the Slit family and transforming growth factor β (TGFβ). 6, 7 CNTF and LIF are predominantly expressed in the embryonic choroid plexus, which suggests that they are developmentally regulated. Of late, the insulinlike growth factors (IGFs) have received considerable attention owing to their pres ence in the CSF and their actions on NSCs and neural progenitor cells. Contemporary data support a role for IGFII in the promotion of n eurogenesis in NSCs in both the SVZ and the SGZ. [8] [9] [10] Disruption of the homeostasis of the CSF has numer ous consequences for the central nervous system (CNS), such as those that occur with ageing or after injury. The CSF regulates and supports the development, division and migration of cells. In fact, changes in the composition and concentrations of proteins in the CSF are required for stemcell maintenance. 2 If the flow of the CSF is disrupted by injury or disease, neurons cannot migrate properly 7 and the clearance of toxins from the brain and the nutrient supply to the brain are reduced. 2, 11 The levels of certain growth factors, for example IGFII, are tightly controlled and modulated after brain injuries, such as cortical trauma, and are essential for wound healing, which helps to bring the system back to homeostasis. 12 In the following sections, we discuss the structure of the neurogenic regions in the CNS and the functions of IGFs in the CNS and in stemcell biology. We also present current data on the neurogenic niche and propose a role for the choroid plexus and IGFII in maintaining NSCs in the SVZ. Although the majority of data on these topics is derived from rodent studies, we indicate similarities or differences in humans from the available information. located between the granular layer and the hilus. During the development of the CNS, NSCs produced by the germinal matrix initiate formation of the hippocampus from midgestation of the embryo onwards and produce a small but mature structure by postnatal week 1. 13, 14 The cells of the SGZ continue to produce new neurons into adulthood. 15, 16 NSCs of the SGZ are typically defined as radial astrocyte like cells that are highly polarized and distrib uted across the dentate gyrus. The proximal domain of each NSC contacts a blood vessel and has lateral processes that frequently contact other radial cells. These radial cells also contain a primary cilium oriented towards the hilus. 17 SGZ radial cells produce intermediate progenitor cells that go on to generate neurons, which migrate to the innergranule cell layer, differentiate into dentategranule cells and establish connections between the molecular layer and CA3 regions (which function in shortterm spatial memory formation) of the hippocampus. 18 The SVZ emerges from the ventricular zone during embryonic development and is a region of small densely packed cells that expands dorsolaterally, producing a triangular shaped region underneath the ependymal cells that line the lateral ventricle. The SVZ extends rostrally from the caudal tip of the lateral ventricle to the olfactory bulb and as far caudally as the fourth ventricle. The ven tricular zone involutes as the animal develops while the SVZ rapidly increases in size. 90% of mouse SVZ cells are actively dividing by embryonic day (E) 16 . 19 The size of the SVZ peaks during the first week of postnatal development in rodents and at ~35 weeks gestation in humans. [20] [21] [22] [23] [24] [25] Early SVZ cells are predominantly neurogenic, whereas in late gestation and in the early postnatal period SVZ cells predominantly generate astrocytes and subsequently oligodendrocytes. Once glio genesis begins to slow down, the SVZ begins to involute; 20 however, a portion of the SVZ persists into adulthood. Much attention has been focused on the adult SVZ in rodents, as cells from the SVZ migrate rostrally via chain migration to the olfactory bulb where they replace a variety of interneurons. 26, 27 The adult human SVZ has been postulated to also produce olfactory bulb inter neurons; 28 however, more contempo rary studies suggest that the production of olfactory bulb neurons from SVZ precursors becomes undetectable after the age of 4 years. 29 Therefore, although the adult human SVZ has the potential to make new neurons, 30 its primary function is to serve as a source of new glial cells. 25 The organization of the adult SVZ has been intensively studied. Early electron microscopy studies deconstructed the adult rodent SVZ into two constituent cell types. 31 The discovery of slowly dividing cells in the adult SVZ that possess the properties of stem cells initiated new inves tigations to improve the definition of the composition of the adult SVZ. In 1997, ultrastructural and immuno histochemical examination was used to classify the cells of the adult SVZ into six cell types (excluding resident microglia): NSCs (type B 1 ); immature astrocytes (type B 2 ); transitamplifying cells (type C); neuroblasts (type A); tanycytes (type D); and ependymal cells (type E). 32 NSCs are descendants of radial glial cells and retain some of their properties. 33, 34 NSCs are located in the most medial aspect of the SVZ and are fairly quiescent, polarized cells that contact the ventricle via an apical process that contains a single primary cilium. 35, 36 NSCs also have a basal process that contacts blood vessels. 1 The other cell types of the adult SVZ, such as immature astrocytes, neuroblasts and transitamplifying cells, are organized in a complex cyto architecture. 32, 37 In the immature animal, the SVZ is even more complex, as it contains large numbers of bipoten tial glialrestricted precursors as well as oligodendrocyte progenitors (Figure 2) . 38, 39 These glialrestricted precur sors persist into adulthood and function as replacements for degenerating whitematter glial cells. 40 From the large number of studies that have perturbed the delicate microenviron ment of the SVZ, it is obvious that NSCs receive and respond to signals from their environment.
A major source of the factors that regulate NSCs in the SVZ is the choroid plexus, which has been neglected in many current models of the NSC niche. The choroid plexus, which produces CSF, has classically been regarded as a toxinremoval and wasteremoval system for the brain. However, the choroid plexus and the CSF are now recognized as rich sources of poly peptides, growth factors and hormones. The remainder of this Review focuses pri marily on the SVZ and studies support ing the view that IGFII produced by the choroid plexus is a component of the NSC niche in the SVZ.
The choroid plexus, CSF and IGFs
The choroid plexus is a highly vascularized organ with a leaflike structure that is located in the lateral, third and fourth ventricles. It consists of a single layer of cuboidal epitheliallike cells that are covered with microvilli and cilia on the external side that contacts the CSF. Tight junction components claudin and occludin are present between the epithelial cells, sealing in the central stroma that contains both fibroblasts and fenestrated capil laries. 41, 42 The choroid plexus produces both CNTF and LIF, which promote maintenance of the NSCs. Poly peptides produced by the choroid plexus diffuse from their source within the ventricles to the NSC niche, thereby establishing a gradient in which the highest levels of poly peptides, such as LIF, are observed closest to the ven tricles. 6 Similarly, Slit proteins form a gradient in the SVZ. 7 The choroid plexus is also the major source of IGFII in the fetal and adult brain, although IGFII is also expressed in leptomeninges and in endothelial cells. 43, 44 IGFs are developmentally regulated and their expres sion levels change as the organism ages. Interest ingly, levels of IGFI were markedly higher in the CSF of chil dren <6 months of age than in the CSF of older children; conversely, levels of IGFII were considerably higher in the CSF of older children than in the CSF of children <6 months of age. 45 Examination of levels of Igf1 mRNA in mice by use of in situ hybridization revealed a decline in levels of IGFI in the SVZ at postnatal week 2. 46 The tran sient elevation in levels of IGFI corresponds to a stage in development in which oligodendrocyte differentiation and myelination occurs; at the same time, levels of IGFII are increased during the maintenance of the NSC niche within the SVZ and persist throughout life. Decreased IGF expression correlates with ageing; circulating levels of IGFI decline ~14% per decade in humans, and levels of IGFII within the CSF of sheep also decline with age. [47] [48] [49] Several studies have investigated the regulation and function of IGFII within the choroid plexus. Levels of IGFII and its biological activity are modulated by IGFBP2, which is also expressed in the choroid plexus 50 and regulates the uptake of IGFII between the choroid plexus epithelial cells and the CSF in young but not old sheep. 48 IGFII has an autocrine and/or paracrine func tion in sustaining the choroid plexus epithelial cells; therefore, as levels of IGFII decline with age, the choroid plexus also continues to degenerate. 51 Despite evidence showing that IGFII is present in CSF, that its expression is regulated with age, and that its levels remain elevated in comparison with those of IGFI, IGFII has received little attention in stemcell research.
The IGF system in growth
Functional studies in mice and the identification of muta tions in humans have demonstrated that IGF ligands and their receptors are important mediators of mammalian growth and development. Elegant knock out studies in mice have provided insights into the functions and inter actions of the IGF ligands and their receptors. 52, 53 Data from null mutant mice support the conclusion that IGFII is not required for early embryogenesis, but is required for organ and body growth beginning at E9 or E10; the size of the resulting pups was ~60% of the normal size at birth (Table 1) . 54, 55 Igf1 null mice are also born 60% of normal size, and have low survival. 56 However, the Igf1 null mice that survive continue to display growth retardation post natally, as IGFI is the major mediator of the effects of growth hormone on postnatal body growth.
The receptors for the IGF ligands include the IGFI receptor, the insulin receptor, the hybrid r eceptor (a hetero dimer of the IGFI receptor and the insulin recep tor) and the IGFII receptor (also known as cation independent mannose 6phosphate receptor). [57] [58] [59] [60] Both IGFI and IGFII bind with high affinity to the IGFI receptor and the hybrid receptor. IGFII is distinct from IGFI in that it also binds with high affinity to the insulin receptor isoform A (IRA) and the IGFII receptor. However, IGFII binding to the IGFII receptor functions primarily to remove IGFII from the extracellular space, and the IGFII receptor is not generally considered an IGF growth signalling receptor. 61 Knock out of Igf1r in mice results in a greater growth deficit at birth than that produced by knocking out the gene encoding either ligand (Igf1 or Igf2) alone, and results in complete perinatal lethality (Table 1) . 56 Insr (encoding the insulin receptor) null mice also display growth defects in late embryogenesis, but loss of the insu lin rceptor is partially compensated for by a doub ling of the levels of the IGFI receptor. 56 Igf1r;Igf2 and Igf1r;Insr doublenull mice are phenotypically indistin guishable and have a greater growth deficit at birth than Igf1r;Igf1 doublenull mice. 52, 53 These findings provided the initial indication that IGFII might have additional functions that are mediated through the insulin recep tor, in addition to those mediated through the IGFI receptor. 62 Interestingly, at E12.5 IGFII exerts 90% of its effects through the IGFI receptor and 10% via the insulin receptor, but by E18.5 this split shifts to 60% and 40%, respectively. The receptordependent effects of IGFII might depend on the expression level of the receptors. 62 Interestingly, the shift in IGFII actions through the insulin receptor corres ponds to a stage in development when the SVZ is rapidly dividing. 19 Igf2 is an imprinted gene and is expressed only from the paternally inherited allele, with the exception of the brain, in which there is biallelic expression. 63 Furthermore, studies of pater nal Igf2 null mice suggest that levels of IGFII at E9 or E10 determine the size of the organism. 54 Cumulatively, these data suggest that the blasto cyst and early embryo form properly in Igf2 null mice as growth deficits do not occur until after E9 or E10. However, perturbations of the IGFII pathway have developmental consequences, as reflected in the Igf2 null mouse phenotype, which are partly attributable to IGFII activity that is mediated via the insulin receptor. 56, 62 Subsequent to the genetic studies showing IGFII effects through the insulin receptor, high expression levels of IRA were observed in fetal cells and tissues, and IRA was shown to bind IGFII with an affinity similar to the affinity of insulin for IRA. 57, 59 Conversely, the affinity of insulin receptor isoform B for IGFII is 20fold lower than that of IRA, which sup ports the conclusion that the effects of IGFII in fetal growth and development are predominant ly mediated through IRA. 64 Deficits in brain growth and differentiation are appar ent in mice with overexpression or lossoffunction muta tions in genes encoding IGF ligands or receptors and in humans with IGF1 or IGF1R mutations. When IGFI is overexpressed systemically, overgrowth of the organism as well as of individual organs occurs. 65 This overgrowth is most pronounced in the brain, where local produc tion is the main source of the ligand, although IGFI can cross the blood-brain barrier. [65] [66] [67] [68] IGFI promotes prolif eration of all neural precursors in the CNS in vitro and in vivo; conversely, del etion of Igf1 results in a reduction in brain size. 69 Similarly, conditional deletion of Igf1r in CNS precursors results in microcephaly. 70 IGFI and the IGFI receptor have major roles in myelination and the oligo dendrocyte lineage in the CNS. Brains of Igf1 null mice and mice with a conditional deletion of Igf1r in the oligodendrocyte lineage have deficits in the prolifera tion, differentiation and maturation of this lineage, and are hypomyelinated. 71, 72 In humans, mutations in IGF1 or IGF1R are associated with growth defects in utero and during postnatal growth. 73 Of particular interest to this Review are the reports of microcephaly, neuro psychiatric disorders and intellectual deficits r esulting from mutations in IGF1 or IGF1R in humans. [73] [74] [75] IGFs and stem cells Insulin or insulinlike peptides are necessary for growth and maintenance of stem cells in diverse organisms, including Drosophila, C. elegans and zebrafish. Drosophila insulinlike peptides (DILPs), which signal through an insulin receptor that has substantial homology with the human insulin receptor, cooperate with other niche factors to regulate germline stemcell proliferation. 76 For example, DILPs promote maintenance of germline stem cells by enhancing Notch and Ecadherin signal ling. 77 Insulin promotes neuro genesis in Drosophila 78 and the number of neuroblasts is reduced with decreased insulin treatment. 79 By contrast, decreased insulin recep tor signal ling in Drosophila and C. elegans extends life span. 80 In zebra fish, insulin is also required for stemcell and NSC maintenance. Zebrafish have two functional homologues of the human insulin receptor, Insra and Insrb (which are encoded by insra and insrb, respectively); knockdown of insra in zebrafish results in defective CNS growth and differentiation. 81 Similar to the findings in invertebrates and zebra fish, insulin or IGF signalling also regulate the growth of stem cells in mammals. 82 IGFI enhances proliferation and/or differentiation of diverse stemcell populations in rodents and humans, including embryonic stem cells (ESCs), NSCs and mesenchymal stem cells. 83, 84 More contempo rary studies, including those by our group (reviewed in the next section), have described roles for IGFII in NSC maintenance and neural progenitor expansion. 8, 10, [85] [86] [87] IGFII produced by fibroblasts regulates human ESC selfrenewal and survival through the IGFI receptor. 88 Similarly, pluripotency of murine ESCs depends, in part, on regulation of IGFII expression by sonic hedgehog. 89 The effects of IGFs on ESCs have been attributed pre dominantly to the IGFI receptor, as blocking of the IGFI receptor promotes human ESC differentiation. 90 Few studies have addressed the potential roles of IGFII that are mediated through IRA. In IRAoverexpressing fibroblasts that lack the IGFI receptor, IGFII has higher mitogenic activity than insulin, and stimulation of these cells with each ligand results in distinct gene expression profiles. 91 Other studies have also shown that IGFII acti vation of IRA promotes cell proliferation and survival. 92 Cumulatively, these data support a function of IGFII mediated through IRA that is distinct from insulin actions mediated through IRA.
IGFs and neural stem cells

Neurosphere studies
The neurosphere assay has been widely used to study the properties of neural cell precursors, including self renewal, growth and differentiation. [93] [94] [95] [96] Following micro dissection and tissue dissociation, cells are grown in a biochemically defined medium that contains specific growth factors. Under these conditions, only prolifer ating, selfrenewing precursors form a nonadherent neuro sphere. The contributions of IGFs to neural cell biology are often overlooked, as standard, defined culture media containing Bottenstein and Sato supple ments (such as N2 or B27) have superphysiological levels of insulin (4-5 μg/ml; ~1 μM). 97 This insulin concentra tion is ~1,000fold higher than the physio logical levels of insulin and can activate both the insulin receptor and the IGFI receptor. At physio logical levels (~25 ng/ml; 4.4 nM), insulin activates only the insulin receptor. Many studies on the IGF system in vitro have generated incon clusive or contradictory results, probably as a result of the high levels of insulin present in culture media acti vating the IGFI receptor. Carefully conducted studies that have examined the IGF system and neurosphere growth have revealed d istinct roles for these ligands and re ceptors (Table 2) .
Previous studies have endorsed a role for IGFI in differentiation during gliogenesis rather than in NSC regulation, owing to its absence in the ependymal lining and choroid plexus and its low expression around the SVZ. 46 However, murine striatal neural precursors at E14 failed to proliferate in serumfree media containing epidermal growth factor (EGF) and fibroblast growth factor 2 (FGF2) in the absence of insulin; the addition of IGFI restored cell growth and promoted neurosphere formation. 98 Interestingly, providing IGFI for as little as 24 h (in the constant presence of EGF) was sufficient to restore neurosphere production to levels comparable to those achieved by 8 days of continuous exposure to IGFI and EGF; however, neither transient nor continu ous incubation with IGFI and FGF2 recapitulated the effects of treatment with IGFI and EGF. 98 The authors of the study concluded that EGF stimulation of NSC proliferation requires IGFI, but not its continuous pres ence. 98 By contrast, pretreatment of adult rat hippo campal neural precursors with FGF2 increased expression of the IGFI receptor; furthermore, treatment with either FGF2 or IGFI had distinct proliferative effects, which were ad ditive when the ligands were combined. Abbreviations: CNS, central nervous system; EGF, epidermal growth factor; IGF, insulin-like growth factor; SGZ, subgranular zone; SVZ, subventricular zone.
REVIEWS
Studies in our laboratories have focused on cellcycle regulation by activation of the insulin receptor, the IGFI receptor and the EGF receptor (EGFR) in rodent neural precursor cells. These studies demonstrated that high levels of insulin in conjunction with EGFR stimulation are necessary for cellcycle progression of neural precur sor cells, with high levels of insulin acting as a progression factor and EGF acting as a competence factor. 86 Activation of the IGFI receptor by high levels of insulin in stand ard culture media in the presence of EGFR activation results in increased levels of phosphohistone 3, phospho retinoblastoma protein and cyclin D. 86 The increase in the levels of these proteins was not observed in cell culture media that contained either high levels of insulin alone or low levels of insulin plus EGF, which indicates that activation of both the IGFI receptor and EGFR are neces sary for cellcycle progression. Fewer neurospheres are produced when excess insulin is replaced by IGFI; these conditions are associated with progenitor expansion and preferential production of glial cells both in vitro and following stemcell transplantation into juvenile mouse brains. 8 Collectively, these cell culture studies reveal an important role for IGFI receptor activation and IGFI in p rogenitor cells.
Whereas IGFI and insulin have been the focus of much attention, studies in the past few years have revealed that IGFII promotes expansion and selfrenewal of both SVZ and SGZ NSCs. [8] [9] [10] Replacing the high levels of insulin in cell culture media with IGFII significantly increases production of neurospheres from the postnatal SVZ and enhances NSC selfrenewal, as assessed by differentiation assays, quantitativePCR gene profiling, limitingdilution analysis and in vivo transplantation analyses. 8 Additional studies have strongly corroborated these findings and shown that CSF stimulates the growth of neurospheres in an IGFIIdependent manner. 9, 10 In fact, IGFII in the CSF binds to the primary cilium of NSC that protrudes into the lateral ventricles in vivo. 9 Further evidence supports the view that IGFII promotes the maintenance of NSCs in the SGZ of the hippo campus. 10 Fluorescenceactivated cell sorting of hippocampal cells that expressed green flu orescent protein under the control of the Sox2 promoter facilitated the isolation of neural precursors for micro array analysis and the identifi cation of genes that were enriched in these putative stem cells; one of the genes identified in the analysis was Igf2. 10 Further characteri zation of IGFII expression in the hippo campus showed that a lentivirus containing a short hairpin RNA against Igf2 decreased proliferation of neural precursors; a similar experiment in SVZ cells using the same short hairpin RNA had no effect on SVZ cell proliferation. 10 These results are consistent with expression data, which shows that unlike the neural precursors in the dentate gyrus, the NSCs of the SVZ do not produce IGFII. 8 Instead, the choroid plexus produces IGFII that functions in the NSC niche within the SVZ. Cumulatively, these data support an important role for IGFII in promoting neurogenesis in both SVZ and SGZ NSCs. Mouse neurospheres grown in the presence of IGFII and transplanted into an age equivalent brain contain cells that home to the NSC niche within the SVZ, 8 which further supports the notion that these cells receive signals from the niche and that IGFII enhances the NSC phenotype and the capacity to respond to those signals.
Although Igf2 is imprinted in peripheral mesodermal and endodermal tissues, it is biallelically expressed in the choroid plexus. 63, 100 Considerable complexity in the expression of imprinted loci, including Igf2, exists in differ ent regions of the brain. [101] [102] [103] Igf2 is predominantly maternally expressed in the adult hippocampus of rats, yet the imprinting status and expression of Igf2 can be altered in a sexspecific and strainspecific manner in the progeny of female rats who are subjected to caloric restric tion. 104 Biallelic expression of Igf2 in the choroid plexus is possibly the result of a need for high levels of IGFII in the CSF, as the source of this protein is not immediately adjacent to the NSCs in the SVZ. Although the imprinting status of Igf2 expression in the Sox2 + neural precursors of the adult dentate gyrus has not been directly examined, if it is regulated similarly to that reported in the hippo campus of rats, then the expression of Igf2 might be more tightly regulated than previously thought and might vary depending on physiological conditions.
To determine whether the actions of IGFII on NSCs are mediated via IRA, we characterized the effect of IGFII on the constituent cells of the neurosphere and found that IGFII or an IGFII protein with the Phe19Ala mutation (which does not bind to the IGFII receptor), increased the proportion of NSCs; these experiments used a novel flow cytometry method that enabled eight antigenically unique neural precursors to be analysed simultaneously. 87, 105 By use of a blocking antibody to the IGFI receptor, the effects of IGF2 Phe19Ala on NSCs were shown to be independ ent of the IGFI receptor. 87, 105 Additionally, neurospheres demonstrated little to no growth when only the IGFII receptor was stimulated (using another mutated IGFII protein, with a Val43Met substitution). 87, 105 Furthermore, IRA is more highly expressed than the IGFI receptor within the medial SVZ, which contains the NSC niche; conversely, the IGFI receptor is more highly expressed than IRA in the lateral SVZ, which is a progenitorcell domain of the SVZ (Figure 3) . 8 IRA is also the predomi nant isoform expressed in neurospheres and, as cells become lineagerestricted, the levels of IRA decrease. The functional correlation between IGFII manipulation and NSCs is beginning to be unveiled through behavioural studies, but much work is still needed to establish whether IGFII is essential for NSC homeostasis in vivo.
New data have shown that hippocampal memory retention and fear extinction in rodents are IGFII dependent. 106, 107 Blocking IGFII with a specific anti body inhibited contextual fear extinction, which is hippocampal dependent. 106 Moreover, a tyrosine kinase inhibitor of the IGFI receptor negated the effects of IGFII on fear extinction; however, it is important to note that this inhibitor has crossreactivity with the insulin receptor tyrosine kinase and, therefore, inhibition of IRA in this study could not be ruled out. 108 Delivering IGFII directly into the hippocampus enhanced memory retention and prevented memory loss during inhibitory avoidance training. 107 This result supports the notion that the actions of IGF2 on hippocampal memory are mediated via the IGFII receptor, 106, 107 probably indirectly through modula tion of the endocytic pathway. 109 Another study provided further evidence that overexpression of Igf2 in the hippo campus of wildtype mice enhances memory and corre lates with the formation of dendritic spines. 110 IGFII also reduced amyloid levels in transgenic mice overexpressing amyloid precursor protein, and the reduction in levels of amyloid in cells in vitro was dependent on the IGFII receptor. Although cell culture studies have demonstrated that IGFII functions via IRA to promote selfrenewal and expansion of rodent SVZ NSCs, 8, 87 the effects of IGFII are probably not limited to a single receptor or a single interaction. A complex interplay that depends on cell type, location and the expression pro file of the IGFII receptor probably determines the out come of IGFII actions on the different NSC and progenitor cell populations.
Conclusions
Despite efforts to elucidate the roles of the ligands in the IGF system, many questions still remain unanswered.
On the basis of the latest information, we propose a model for SVZ neuralstemcell homeostasis whereby IGFII produced by the choroid plexus functions via the insulin receptor on the NSCs located adjacent to the ependymal layer along the lateral ventricles (Figure 3) . The NSCs in the medial SVZ express high levels of IRA. Moving laterally, the concentration of IGFII in the tissue decreases and the composition of the SVZ changes to contain more progeni tor cells. Progenitor cells express more IGFI receptor and are more responsive to IGFI than to IGFII. Within the hippocampus, IGFII is locally produced by progenitors or the NSCs themselves, which suggests that hippocampal IGFII is probably regulated differently from that produced by the choroid plexus. Testing this model will require per turbation of the levels of IGFII and its receptors in the adult CNS to determine the effects on neurogenesis in both the SVZ and the hippocampus. Consistent with the many parallel studies discussed in this Review, IGFII possibly exerts both shortterm and longterm effects, which are mediated via distinct receptors.
Associations are emerging between the IGF system and Alzheimer disease, schizophrenia and other neuro logical disorders. Gaps in our knowledge exist because we have yet to unravel the functions of this complex growth factor system in the nondisease state. For example, what role, if any, do IGFII and the insulin receptor have in tumori genesis within the CNS? The insulin receptor, and more specifically IRA, is abnormally expressed in many tumour cell lines and primary tumours, including those of the breast, colon and thyroid gland. 111 Therefore, might IGFII and IRA participate in maintaining cancer stem cells in one or more types of CNS tumours? Furthermore, how IGFII ligand binding to IRA promotes neural stemness is not known. Does this binding affect Notch and Ecadherin signalling in the mammalian NSCs as it does in Drosophila? It is apparent that there are gaps in our knowledge about the effects of the individual compo nents of the IGF system as well as their sources in vivo and their contribution to overall health and disease. Moving forward, the IGF system will be integral to the study of NSCs and, perhaps, of stem cells in other organs. The subventricular zone and its subregions are depicted. Within the lateral ventricle, the choroid plexus produces cytokines and growth factors that maintain the stemness of the primitive neuroepithelial precursors that reside in the SVZ niche. The choroid plexus produces IGF-II, which stimulates the primitive neural precursors in the most medial aspect of the subventricular zone via IR-A, which is highly expressed in this subregion. By contrast, IGF-I and the IGF-I receptor are more highly expressed in the lateral aspect of the subventricular zone, which has few NSCs but a large number of lineage-restricted progenitors. Abbreviations: IGF, insulin-like growth factor; IR-A, insulin receptor isoform A; NSC, neural stem cell.
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